Composition for Treatment, Inhibition and Attenuation of Virus

US 9,694,030, assigned to Sawaya Medical Patents LLC, relates to medical technology, and is available for sale or license through IPApproach.

US Patents

1 granted

Assignee

Sawaya Medical Patents LLC

Availability

For Sale or License

Patents Included

• US 9,694,030↗

Technology Highlights

• The invention can be used against the plurality of virus including ebola virus, herpes virus, dengue virus, smallpox virus, measles virus, mumps rubella virus, HIV (human immunodeficiency virus), lassa fever virus, yellow fever virus, cancer and solid tumors, especially the fibrosarcoma tumor.
• The invention composition could be given orally, intravenously, inhalation, intravesical, vaginal, rectal, sublingual, ophthalmic, or topical and was tested by UBC 2016.
• The invention sodium thiosulfate (STS) is used for treating neurodegenerative disorders that has a prominent neuro-inflammatory component.
• The cost of invention sodium thiosulfate (STS) IV or oral could be to treat Sarcoma is 100 times less than any known treatment in the world.
• The invention is unique and offers a proven way for -H2S (hydrogen sulfide) being safe for human, copious amounts of H2S to bind metals in humans and in the environment, water and animals and killing viruses and cancers and more.

Overview

The invention disclosed provides the following advantages:

Listing updated August 21, 2026

IPApproach lists patents and portfolios where the seller has not requested anonymity or confidentiality. Patent numbers link to public records on Google Patents.